Zepbound® (tirzepatide) peak-dose FDA reference. Compounded versions are not FDA-approved. Individual results vary and are not guaranteed.
“Down 34 lbs and my bloodwork finally looks right. My doctor adjusted my dose twice — it actually felt built around me.”
Mounjaro®Rx
Tirzepatide — dual-action GLP-1 / GIP
Available soon — see our compounded version in the meantime
Take control of your health.
Doctor-guided care, prescribed and dosed by a licensed physician — Dr. Taylor, doctor-supported.
Why Mounjaro®Rx
Brand-name tirzepatide from Eli Lilly
Dual-action GLP-1 / GIP
Once-weekly injection pen
Physician-prescribed after a medical review
Mounjaro® vs Compounded Tirzepatide
Mounjaro® is a registered trademark of Eli Lilly and Company. Bon Health is not affiliated with or endorsed by Eli Lilly.
The Standard of Care.
Most platforms prioritize the transaction. We prioritize the protocol. Compare the Bon Health clinical framework against generic telehealth.
Important Safety Information
Prescription products require an online evaluation with a licensed physician, who determines whether treatment is appropriate for you. Compounded medications are not FDA-approved; the FDA does not review compounded drugs for safety, effectiveness, or quality.
GLP-1 and GIP/GLP-1 medications may cause side effects — including nausea, vomiting, diarrhea, constipation, and abdominal pain — and carry warnings regarding the risk of thyroid C-cell tumors. Tell your physician about your full medical history, current medications, and any history of pancreatitis, gallbladder disease, or thyroid cancer before starting treatment.
Individual results vary and are not guaranteed. This information is provided for educational purposes only, is not medical advice, and is not a substitute for the judgment of your licensed clinician. See our Medical Disclaimer, and never disregard or delay professional medical advice based on content here. If you are experiencing a medical emergency, call 911 or go to the nearest emergency room.
† Prices reflect medication only. Bon Health charges no membership fee — the per-month price for your chosen commitment tier is what you pay, billed monthly or quarterly depending on the plan you select. Medication is dispensed only following an online consultation with a licensed healthcare provider, who determines whether a prescription is clinically appropriate based on their independent clinical judgment.
Compounded Semaglutide and Compounded Tirzepatide are not FDA-approved. The FDA does not evaluate compounded medications for safety, effectiveness, or quality. These preparations are dispensed by U.S.-licensed 503A and 503B compounding pharmacies. Prescription products require a licensed provider's evaluation.
Semaglutide is the active ingredient in Ozempic® and Wegovy®, FDA-approved products of Novo Nordisk A/S. Tirzepatide is the active ingredient in Mounjaro® and Zepbound®, FDA-approved products of Eli Lilly and Company. Bon Health is not affiliated with, sponsored by, or endorsed by Novo Nordisk A/S or Eli Lilly and Company. Ozempic®, Wegovy®, Mounjaro®, and Zepbound® are registered trademarks of their respective owners.
Availability varies from state to state. Prescription required. Weight Loss by Bon Health is a doctor-guided program that includes ongoing clinical support, direct messaging with your care team, and medications prescribed based on what your provider determines is medically appropriate and necessary for you.